Literature DB >> 32714519

Management of Hepatitis C-Infected Patients After Sustained Virological Response.

Brian Pearlman1,2,3.   

Abstract

Watch an interview with the author Answer questions and earn CME.
© 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2020        PMID： 32714519      PMCID： PMC7373773          DOI： 10.1002/cld.913

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  9 in total

1.  Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population.

Authors:  Savino Bruno; Vito Di Marco; Massimo Iavarone; Luigi Roffi; Andrea Crosignani; Vincenza Calvaruso; Alessio Aghemo; Giuseppe Cabibbo; Mauro Viganò; Vincenzo Boccaccio; Antonio Craxí; Massimo Colombo; Patrick Maisonneuve
Journal:  J Hepatol       Date:  2016-04-05       Impact factor: 25.083

2.  The Changing Scenario of Screening and Surveillance of Esophageal Varices.

Authors:  Roberto de Franchis
Journal:  Gastroenterology       Date:  2019-02-15       Impact factor: 22.682

3.  Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.

Authors:  Fabrice Carrat; Hélène Fontaine; Céline Dorival; Mélanie Simony; Alpha Diallo; Christophe Hezode; Victor De Ledinghen; Dominique Larrey; Georges Haour; Jean-Pierre Bronowicki; Fabien Zoulim; Tarik Asselah; Patrick Marcellin; Dominique Thabut; Vincent Leroy; Albert Tran; François Habersetzer; Didier Samuel; Dominique Guyader; Olivier Chazouilleres; Philippe Mathurin; Sophie Metivier; Laurent Alric; Ghassan Riachi; Jérôme Gournay; Armand Abergel; Paul Cales; Nathalie Ganne; Véronique Loustaud-Ratti; Louis D'Alteroche; Xavier Causse; Claire Geist; Anne Minello; Isabelle Rosa; Moana Gelu-Simeon; Isabelle Portal; François Raffi; Marc Bourliere; Stanislas Pol
Journal:  Lancet       Date:  2019-02-11       Impact factor: 79.321

4.  Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.

Authors:  Dominique Thabut; Christophe Bureau; Richard Layese; Valérie Bourcier; Maryam Hammouche; Carole Cagnot; Patrick Marcellin; Dominique Guyader; Stanislas Pol; Dominique Larrey; Victor De Lédinghen; Denis Ouzan; Fabien Zoulim; Dominique Roulot; Albert Tran; Jean-Pierre Bronowicki; Jean-Pierre Zarski; Odile Goria; Paul Calès; Jean-Marie Péron; Laurent Alric; Marc Bourlière; Philippe Mathurin; Jean-Frédéric Blanc; Armand Abergel; Lawrence Serfaty; Ariane Mallat; Jean-Didier Grangé; Pierre Attali; Yannick Bacq; Claire Wartelle-Bladou; Thông Dao; Christophe Pilette; Christine Silvain; Christos Christidis; Dominique Capron; Brigitte Bernard-Chabert; Sophie Hillaire; Vincent Di Martino; Angela Sutton; Etienne Audureau; Françoise Roudot-Thoraval; Pierre Nahon
Journal:  Gastroenterology       Date:  2019-02-13       Impact factor: 22.682

Review 5.  Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis.

Authors:  Esther J Aspinall; Stephen Corson; Joseph S Doyle; Jason Grebely; Sharon J Hutchinson; Gregory J Dore; David J Goldberg; Margaret E Hellard
Journal:  Clin Infect Dis       Date:  2013-08       Impact factor: 9.079

6.  Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis.

Authors:  Debra T Choi; Hye-Chung Kum; Sulki Park; Robert L Ohsfeldt; Yu Shen; Neehar D Parikh; Amit G Singal
Journal:  Clin Gastroenterol Hepatol       Date:  2018-10-26       Impact factor: 11.382

7.  HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe.

Authors:  Patrick Ingiliz; Thomas C Martin; Alison Rodger; Hans-Jürgen Stellbrink; Stefan Mauss; Christoph Boesecke; Mattias Mandorfer; Julie Bottero; Axel Baumgarten; Sanjay Bhagani; Karine Lacombe; Mark Nelson; Jürgen K Rockstroh
Journal:  J Hepatol       Date:  2016-09-17       Impact factor: 25.083

8.  HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.

Authors:  Nourdine Hamdane; Frank Jühling; Emilie Crouchet; Houssein El Saghire; Christine Thumann; Marine A Oudot; Simonetta Bandiera; Antonio Saviano; Clara Ponsolles; Armando Andres Roca Suarez; Shen Li; Naoto Fujiwara; Atsushi Ono; Irwin Davidson; Nabeel Bardeesy; Christian Schmidl; Christoph Bock; Catherine Schuster; Joachim Lupberger; François Habersetzer; Michel Doffoël; Tullio Piardi; Daniele Sommacale; Michio Imamura; Takuro Uchida; Hideki Ohdan; Hiroshi Aikata; Kazuaki Chayama; Tujana Boldanova; Patrick Pessaux; Bryan C Fuchs; Yujin Hoshida; Mirjam B Zeisel; François H T Duong; Thomas F Baumert
Journal:  Gastroenterology       Date:  2019-03-02       Impact factor: 33.883

9.  HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma.

Authors:  George N Ioannou; Pamela K Green; Kristin Berry
Journal:  J Hepatol       Date:  2017-09-05       Impact factor: 25.083
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.